SCLEROMAX AS

Signals

2 flags

• ▼ Negativ egenkapital 2025 Bokført egenkapital er negativ (−92k kr).
• ▼ Driftsunderskudd 2025 Siste driftsresultat er negativt (−29k kr).

SCLEROMAX AS is registered as a limited company in Oslo, Oslo with organisation number 828331132. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2021. Registered share capital is NOK 30,000, divided into 30000 shares. The company's stated purpose is: “Konsulenttjenester innen medisin, biomedisins forskning og patentering, redaktørvirksomhet og artikkelforfatterskap, samt handel og investering i næringsvirksomhet, herunder aksjer og andeler og deltagelse i andre selskaper med lignende virksomhet.”.

Key figures · 2025

Operating profit

NOK −29,000

Equity

NOK −92,000

Financial health · 2025

Liquidity

0.02

Not satisfactory

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

-4083.3%

Weak

Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns SCLEROMAX AS?

ANSGAR ODDNE AASEN

100.0%

SCLEROMAX AS

· NOK −29,000 profit

SCLEROMAX AS has 1 registered shareholder:

• ANSGAR ODDNE AASEN 100.0%

All shareholders and roles →

Frequently asked questions about SCLEROMAX AS

Who owns SCLEROMAX AS?

ANSGAR ODDNE AASEN is the largest registered owner, with 100.0%.

Who is the general manager of SCLEROMAX AS?

Ansgar Oddne Aasen is registered as general manager of SCLEROMAX AS.

Where is SCLEROMAX AS based?

SCLEROMAX AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.